Erythropoietin-producing hepatocellular A2 (EphA2), a member of the Eph family of receptor tyrosine kinases, is a crucial regulator of tumorigenesis and is highly expressed in multiple cancers, including HCC (Wilson et al., 2021). The gene discussed is EPHA2; the disease is hepatocellular carcinoma.